SynthesisPharmacoEconomics2026

Economic Burden of Idiopathic Pulmonary Fibrosis: Updated Evidence on Costs and Resource Use.

Alexander Diamantopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.